HER
HER inhibitors are compounds that block the activity of Human Epidermal Growth Factor Receptors, particularly HER2, which is overexpressed in certain breast cancers and other malignancies. Inhibition of HER signaling pathways is a key strategy in targeted cancer therapies. At CymitQuimica, we offer HER inhibitors to support your research in oncology, targeted therapies, and cell signaling.
Found 5 products of "HER"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
ABP-102
<p>ABP-102 (CT P72) is a bispecific t-cell adduct (BiTE) that acts as a CD3 modulator and selective HER2 modulator for targeting HER2 overexpressing tumors.</p>Color and Shape:Odour LiquidPanomifene HCl
CAS:<p>Panomifene HCl is a selective anti-estrogenic compound with antitumor activity for the treatment of breast cancer.</p>Formula:C25H25ClF3NO2Purity:99.53%Color and Shape:SoildMolecular weight:463.92HyT36
CAS:<p>HyT36: hydrophobic tag that destabilizes fusion proteins & Her3 pseudokinase; treats cells with acute erht.</p>Formula:C25H44ClNO3Purity:99.86%Color and Shape:SolidMolecular weight:442.07BMS 599626 2HCl
CAS:<p>BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100</p>Formula:C27H29FN8O3Cl2Purity:99.94%Color and Shape:SoildMolecular weight:603.48Fidasimtamab
CAS:<p>Fidasimtamab, a recombinant human IgG1 bispecific antibody, targets both HER2 and PD-1, bridging T cells and tumor cells to modulate immune responses.</p>Purity:95% - 95%Color and Shape:Liquid
